The estimated Net Worth of Julie D. Dewey is at least $2.33 millió dollars as of 17 August 2020. Ms. Dewey owns over 1,421 units of Wright Medical NV stock worth over $1,250,226 and over the last 9 years she sold WMGI stock worth over $1,076,691. In addition, she makes $0 as Senior Vice President és Chief Communications Officer at Wright Medical NV.
Sign up
Ms. Dewey WMGI stock SEC Form 4 insiders trading
Julie has made over 15 trades of the Wright Medical NV stock since 2015, according to the Form 4 filled with the SEC. Most recently she sold 1,421 units of WMGI stock worth $42,857 on 17 August 2020.
The largest trade she's ever made was exercising 119,969 units of Wright Medical NV stock on 18 November 2019 worth over $2,533,745. On average, Julie trades about 6,251 units every 68 days since 2015. As of 17 August 2020 she still owns at least 41,702 units of Wright Medical NV stock.
You can see the complete history of Ms. Dewey stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Julie Dewey biography
Julie D. Dewey serves as Senior Vice President, Chief Communications Officer of the Company. Ms. Dewey served as Senior Vice President, Chief Communications Officer of Wright Medical Group, Inc. from October 2011 to October 2015. Prior to joining legacy Wright, Ms. Dewey served as Chief Communications Officer of Epocrates, Inc., a publicly held company that sold physician platforms for clinical content, practice tools and health industry engagement, from March 2011 to October 2011. From January 2008 to July 2010, Ms. Dewey was Senior Vice President and Chief Communications Officer of ev3 Inc. Prior to ev3, Ms. Dewey held marketing and investor relations positions at Kyphon Inc. from January 2003 to November 2007 and Thoratec Corporation from January 1998 to January 2003. Ms. Dewey currently serves as a member of the board of directors for the National Investor Relations Institute, the professional association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents.
How old is Julie Dewey?
Julie Dewey is 58, she's been the Senior Vice President és Chief Communications Officer of Wright Medical NV since 2015. There are 10 older and 12 younger executives at Wright Medical NV. The oldest executive at Wright Medical Group NV is Robert Palmisano, 75, who is the President and Chief Executive Officer, Executive Director.
What's Julie Dewey's mailing address?
Julie's mailing address filed with the SEC is 1023, Cherry Road, The Village, Memphis, Shelby County, Tennessee, 38117, United States of America.
Insiders trading at Wright Medical NV
Over the last 9 years, insiders at Wright Medical NV have traded over $526,674,381 worth of Wright Medical NV stock and bought 118,654 units worth $2,654,459 . The most active insiders traders include Sean Carney, Elizabeth H Weatherman és Holdings Cooperatief U.A.Wa.... On average, Wright Medical NV executives and independent directors trade stock every 9 days with the average trade being worth of $4,402,563. The most recent stock trade was executed by Tim Lanier on 17 August 2020, trading 951 units of WMGI stock currently worth $28,644.
What does Wright Medical NV do?
Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.
What does Wright Medical NV's logo look like?
Complete history of Ms. Dewey stock trades at Wright Medical NV
Wright Medical NV executives and stock owners
Wright Medical NV executives and other stock owners filed with the SEC include:
-
Robert Palmisano,
President and Chief Executive Officer, Executive Director -
Peter Cooke,
President, Emerging Markets, Australia and Japan -
Lance Berry,
Executive Vice President, Chief Financial and Operations Officer -
Kevin Cordell,
Executive Vice President, Chief Global Commercial Officer -
Andrew Morton,
Senior Vice President, Chief Human Resources Officer -
James Lightman,
Senior Vice President, General Counsel and Secretary -
Barry Regan,
Senior Vice President, Operations -
Jason Asper,
Senior Vice President, Chief Digital Officer -
David Stevens,
Non-Executive Independent Chairman of the Board -
Kevin O'Boyle,
Non-Executive Independent Director -
Elizabeth Weatherman,
Non-Executive Independent Director -
John Miclot,
Non-Executive Independent Director -
Richard Wallman,
Non-Executive Independent Director -
Gary Blackford,
Non-Executive Independent Director -
Amy Paul,
Non-Executive Independent Director -
James Mackin,
Non-Executive Independent Director -
Steven Wallace,
President, International -
Kevin Smith,
Senior Vice President, Quality and Regulatory -
Julie Dewey,
Senior Vice President, Chief Communications Officer -
Timothy Lanier,
President, Upper Extremities -
Patrick Fisher,
President, Lower Extremities -
Julie Andrews,
Senior Vice President, Global Finance -
Jennifer Walker,
Senior Vice President, Process Improvement -
J. Porter,
Senior Vice President, Chief Compliance Officer -
Tim Lanier,
President, Upper Extremities -
Sean Carney,
Director -
William L. Jr Griffin,
SVP GM BioMimetic Therapeutics -
Terry M. Rich,
President, Upper Extremities -
Gregory Morrison,
Sr. VP, Human Resources -
Robert P. Iii Burrows,
SVP, Supply Chain -
David H Mowry,
EVP and COO -
Ummersen Gordon Van,
Sr. VP, Product Delivery -
Holdings Cooperatief U.A.Wa...,
-
Alain Tornier,
Director -
Richard B Emmitt,
Director -
Kevin M Klemz,
Sr. VP, CLO and Secretary -
Shawn Mc Cormick,
Chief Financial Officer -
Medical Group N.V. Wright,
President, Lower Extremities